Rasha Aboelhassan

ORCID: 0000-0003-4755-6105
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Economic and Financial Impacts of Cancer
  • HER2/EGFR in Cancer Research
  • Ear and Head Tumors
  • Colorectal Cancer Screening and Detection
  • Multiple and Secondary Primary Cancers
  • Multiple Myeloma Research and Treatments
  • Lung Cancer Treatments and Mutations
  • Sarcoma Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Pleural and Pulmonary Diseases
  • Bone health and treatments
  • Occupational and environmental lung diseases
  • Cancer Treatment and Pharmacology
  • Vascular Tumors and Angiosarcomas
  • Gastrointestinal disorders and treatments
  • Esophageal Cancer Research and Treatment
  • COVID-19 and healthcare impacts
  • Historical and Modern Theater Studies
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Advances in Oncology and Radiotherapy
  • Neuroendocrine Tumor Research Advances
  • Acute Myeloid Leukemia Research

Nasser Institute hospital
2015-2023

clinical oncology value framework AVF are different stakeholders' frameworks to help assess the of regimens [5,6].Oncologists have perspectives for affordability cancer therapy in regions, which result cost-efficacy treatment [7].Also, there is certain relation between and efficacy countries [8].This article will address affordability, efficacy, safety GIT EGYPT. MethodsSafety grades version 2021 NCCN evidence-based blocks used as reference protocols.Egyptian populations were divided...

10.31038/cst.2022713 article EN Deleted Journal 2022-01-11

Abstract Background:Globally, triple-negative breast cancer (TNBC) is responsible for approximately 15% of all invasive Breast and has been typically associated with poor prognosis. Some retrospective studies have suggested a relatively higher incidence TNBC in the Middle East North African Arab countries. Nevertheless, there complete lack prospective data, on region, including clinico-pathologic characteristics, treatment patterns disease outcomes. The TRIPOLI study aims to bridge this...

10.1158/1538-7445.sabcs20-ps7-65 article EN Cancer Research 2021-02-15

Stage III non-small cell lung cancer (NSCLC) being highly heterogeneous requires multimodal therapeutic strategies for optimal management. We present findings on treatment patterns and their associated survival outcomes in patients with stage NSCLC from the Egypt subset of KINDLE global real-world study conducted across countries Asia, Middle East, Africa, Latin America.Retrospective data (21 centers) adult diagnosed between January 2013 December 2017 were analyzed. Descriptive inferential...

10.1177/17588359231212182 article EN cc-by-nc Therapeutic Advances in Medical Oncology 2023-01-01

"CLO22-053: Risk Factors of Paclitaxel Induced Peripheral Neuropathy in Early Breast Cancer Patient Relation to Mean Changes Growth and Serum Malondialdehyde" published on 31 Mar 2022 by National Comprehensive Network.

10.6004/jnccn.2021.7159 article EN Journal of the National Comprehensive Cancer Network 2022-03-31
Coming Soon ...